/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Daxor Corp

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$12.8 -0.0344(-3.44%) DXR at 04 Dec 2025 04:30 PM Medical Instruments & Supplies
Lowest Today 13.18
Highest Today 13.45
Today’s Open 13.45
Prev. Close 13.1
52 Week High 14.15
52 Week Low 6.55
Day’s Range: Low 13.18 High 13.45
52-Week Range: Low 6.55 High 14.15
1 day return -
1 Week return -
1 month return -0.39
3 month return +9.63
6 month return +27.5
1 year return +41.03
3 year return +34.06
5 year return +2.53
10 year return -

Institutional Holdings

Vanguard Group Inc 0.98

Vanguard Total Stock Mkt Idx Inv 0.96

Renaissance Technologies Corp 0.56

Keyes Stange & Wooten Wealth Management LLC 0.32

Morgan Stanley - Brokerage Accounts 0.07

SBI Securities Co Ltd 0.06

NT Quality SCC US Fund - L 0.01

NT Quality Small Cap Core 0.01

Gabelli Global Mini Mites I 0.01

Northern Small Cap Core I 0.00

JPMorgan Chase & Co 0.00

Advisor Group Holdings, Inc. 0.00

Princeton Global Asset Management LLC 0.00

UBS Group AG 0.00

Wells Fargo & Co 0.00

Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 65.30 M

PB Ratio 1.8327

PE Ratio 81.875

Enterprise Value 42.93 M

Total Assets 36.63 M

Volume 702

Company Financials

Annual Revenue FY23:34590261 34.6M, FY22:6310294 6.3M, FY21:5821183 5.8M, FY20:-996299 -1.0M, FY19:-114992 -0.1M

Annual Profit FY23:34413186 34.4M, FY22:6310294 6.3M, FY21:5821183 5.8M, FY20:-996299 -1.0M, FY19:-114992 -0.1M

Annual Net worth FY23:280640 0.3M, FY22:5178133 5.2M, FY21:4748197 4.7M, FY20:-1705391 -1.7M, FY19:-495697 -0.5M

Quarterly Revenue Q2/2025:18348 0.0M, Q2/2024:71756 0.1M, Q1/2024:35878 0.0M, Q4/2023:36350797 36.4M, Q3/2023:41224 0.0M

Quarterly Profit Q2/2025:18348 0.0M, Q2/2024:71756 0.1M, Q1/2024:35878 0.0M, Q4/2023:36355433 36.4M, Q3/2023:41224 0.0M

Quarterly Net worth Q2/2025:-369701 -0.4M, Q2/2024:-1630818 -1.6M, Q1/2024:-815409 -0.8M, Q4/2023:4806347 4.8M, Q3/2023:1658911 1.7M

Fund house & investment objective

Company Information Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

Organisation Medical Instruments & Supplies

Employees 0

Industry Medical Instruments & Supplies

CEO Mr. Michael Richard Feldschuh

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow